Mr. Speaker, that is a legitimate question. We believe that the time has come to send this bill back to Canadians, to do it properly. The bill has too many flaws that are going to create problems later on. That is the reason why we have said it is time to back this up. There are some things that could be done in the interim to protect the safety of Canadians, not only through the health department but also through other departments.
If we send the bill to committee, the fear that we have is that there will not be enough of a bill left over to actually have something progressive and supportable at the end of the day. We would prefer to see a re-engagement on this so we can get it right. We have had to go through this many times.
This is the fifth or sixth time we have cycled through the bill. Unfortunately, it has always been flawed by the influence of big pharma. We need to pull that out and do it properly. We would support that process.